Analysis of the latest price trend of Eltrombopag/Eltrombopag in 2025 to help you make a reasonable purchase!
As an innovative therapeutic drug, Eltrombopag has achieved significant clinical efficacy, but its price is relatively high due to its research and development costs and the complexity of the production process, especially in some areas. Understanding the price trend of Eltrombopag can help patients choose the most suitable purchasing channel based on their own financial situation.
In the Chinese market, the original drug of Eltrombopag is usually marketed as Eltrombopag ethanolamine tablets, with common specifications: 25mg 14 tablets and 25mg 28 tablets. According to market research, the price of original drugs is roughly between RMB 2,000 and RMB 4,000. It is worth noting that Eltrombopag has been included in China’s Class B medical insurance, and for patients who meet the indications, part of the cost can be reimbursed through medical insurance.
This greatly reduces the financial burden on patients. Especially for patients who require long-term treatment, the reimbursement policy of medical insurance is extremely important. However, not all patients can enjoy medical insurance benefits. Patients need to know whether they meet the reimbursement conditions when purchasing drugs. Patients who do not meet the conditions need to bear the cost of the drugs themselves.
In the international market, the price of eltrombopag varies greatly. In Türkiye and India, the original price of eltrombopag is usually around RMB 1,000. Although the price is cheaper than domestically, it is also affected by exchange rate fluctuations, so the price may fluctuate. In some developing countries, such as Bangladesh, Laos and India, generic drugs of eltrombopag have entered the market. The ingredients of these generic drugs are similar to the original drugs and the efficacy is basically the same. The price of generic drugs is usually relatively low, with a box costing about a few hundred yuan. For patients with greater financial pressure, choosing generic drugs is undoubtedly a more cost-effective option.
Reference materials:https://go.drugbank.com/drugs/DB06210
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)